|
|
K R Cooke, G R Hill, J M Crawford, D Bungard, Y S Brinson, J Delmonte, J L Ferrara
J Clin Invest. 1998;
102(10):1882
doi:10.1172/JCI4285
Abstract |
Full text
| PDF

D
onor T cell responses to host alloantigen are known predictors for graft-versus-host disease (GVHD); however, the effect of donor responsiveness to an inflammatory stimulus such as lipopolysaccharide (LPS) on GVHD severity has not been investigated. To examine this, we used mouse strains that differ in their sensitivity to LPS as donors in an experimental bone marrow transplant (BMT) system. Lethally irradiated (C3FeB6)F1 hosts received BMT from either LPS-sensitive (LPS-s) C3Heb/Fej, or LPS-resistant (LPS-r) C3H/ Hej donors. Mice receiving LPS-r BMT developed significantly less GVHD as measured by mortality and clinical score compared with recipients of LPS-s BMT, a finding that was associated with significant decreases in intestinal histopathology and serum LPS and TNF-alpha levels. When donor T cell responses to host antigens were measured, no differences in proliferation, serum IFN-gamma levels, splenic T cell expansion, or CTL activity were observed after LPS-r or LPS-s BMT. Systemic neutralization of TNF-alpha from day -2 to +6 resulted in decreased intestinal pathology, and serum LPS levels and increased survival after BMT compared with control mice receiving Ig. We conclude that donor resistance to endotoxin reduces the development of acute GVHD by attenuating early intestinal damage mediated by TNFalpha. These data suggest that the responsiveness of donor accessory cells to LPS may be an important risk factor for acute GVHD severity independent of T cell responses to host antigens.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(17)
| Title and authors |
Publication |
Year |
Low doses of natural killer T cells provide protection from acute graft-versus-host disease via an IL-4-dependent mechanism
D. B. Leveson-Gower, J. A. Olson, E. I. Sega, R. H. Luong, J. Baker, R. Zeiser, R. S. Negrin
|
Blood
|
2011 |
Role of gut microbiota in graft-versus-host disease
Stephen Murphy, Vu H. Nguyen
|
Leuk Lymphoma
|
2011 |
HIV and hepatitis C coinfection
Emma E. Page, Mark Nelson, Peter Kelleher
|
Current Opinion in HIV and AIDS
|
2011 |
Inhibition of IL-32 activation by -1 antitrypsin suppresses alloreactivity and increases survival in an allogeneic murine marrow transplantation model
A. M. Marcondes, X. Li, L. Tabellini, M. Bartenstein, J. Kabacka, G. E. Sale, J. A. Hansen, C. A. Dinarello, H. J. Deeg
|
Blood
|
2011 |
Graft-versus-host disease: regulation by microbe-associated molecules and innate immune receptors
O. Penack, E. Holler, M. R. M. van den Brink
|
Blood
|
2009 |
Cytolytic T cells induce ceramide-rich platforms in target cell membranes to initiate graft-versus-host disease
J. A. Rotolo, B. Stancevic, S. X. Lu, J. Zhang, D. Suh, C. G. King, L. W. Kappel, G. F. Murphy, C. Liu, Z. Fuks, M. R. van den Brink, R. Kolesnick
|
Blood
|
2009 |
Acute graft-versus-host disease: from the bench to the bedside.
Gerard Socié, Bruce R Blazar
|
Blood
|
2009 |
Superagonistic CD28 stimulation of allogeneic T cells protects from acute graft-versus-host disease
N. Beyersdorf, X. Ding, T. Hunig, T. Kerkau
|
Blood
|
2009 |
Soluble lymphotoxin is an important effector molecule in GVHD and GVL
K. A. Markey, A. C. Burman, T. Banovic, R. D. Kuns, N. C. Raffelt, V. Rowe, S. D. Olver, A. L. J. Don, E. S. Morris, A. R. Pettit, Y. A. Wilson, R. J. Robb, L. M. Randall, H. Korner, C. R. Engwerda, A. D. Clouston, K. P. A. MacDonald, G. R. Hill
|
Blood
|
2009 |
Graft-versus-Host Disease Prophylaxis with Tacrolimus and Mycophenolate Mofetil in HLA-Matched Nonmyeloablative Transplant Recipients Is Associated with Very Low Incidence of GVHD and Nonrelapse Mortality
Waleed Sabry, Richard Le Blanc, Annie-Claude Labbé, Guy Sauvageau, Stephen Couban, Thomas Kiss, Lambert Busque, Sandra Cohen, Silvy Lachance, Denis-Claude Roy
|
Biology of Blood and Marrow Transplantation
|
2009 |
|